Health Care Deal News: Spotlight on Biotechnology – December 2011
In the largest deal of the month, one so large that it accounts for slightly more than one-half of all dollars spent on health care M&A, Gilead Sciences (NASDAQ: GILD) is buying Pharmasset, Inc. (NASDAQ: VRUS) for $11.0 billion. Based in Foster City, California,...The Health Care M&A Monthly: Valuing Hospitals Today–
2011 Saw Upward Pressure On Acquisition Multiples During 2011, we saw some upward pressure on the acquisition multiples for hospitals due to competition and a market that expanded over the past four years. The results are reported in Irving Levin’s The Health Care...Health Care Deal News: Spotlight on Venture Capital- February 2012
Warp Drive Bio, a start-up biotech focused on drug development from studying microbes and based in Cambridge, Massachusetts, got itself beamed up $125.0 million in financing. The investor syndicate includes Sanofi (NYSE: SNY) along with founding backer Third Rock...The Health Care M&A Monthly: Catholic Hospital M&A —
Are Acquisitions Restricting Women’s Health Care? Political rhetoric heated up during February when the GOP claimed that the Obama administration was waging war on religious freedom by requiring certain institutions to pay for contraception for their...The Health Care M&A Monthly: Biotechnology Boom–
Sector Announces 11 Deals In February Worth $5.4 Billion February saw the announcement of 11 deals in the Biotechnology sector worth a combined total of $5.4 billion. This activity accounted for 15% of the deal volume but 58% of the all health care M&A...Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
